NCIt definition : An afucosylated, humanized monoclonal antibody against the alpha chain of the interleukin-5
receptor (IL-5Ra), with potential anti-asthmatic activity. Upon administration, benralizumab
binds to IL-5Ra and elicits an antibody-directed cell cytotoxicity (ADCC) against
IL-5Ra-expressing cells. This induces apoptosis in IL-5Ra-expressing cells and may
reduce asthmatic episodes. IL-5Ra, expressed on both eosinophils and basophils, plays
a key role in asthma.;
UNII : 71492GE1FX;
CAS number : 1044511-01-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1044511-01-4
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;